BioCorRx Inc.
BICX
$0.2866
-$0.2034-41.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.25% | -71.70% | -31.97% | -22.49% | 16.49% |
| Total Depreciation and Amortization | -74.11% | -58.07% | -38.20% | -10.00% | 138.08% |
| Total Amortization of Deferred Charges | -1.50% | 46.79% | 183.96% | 112.10% | 264.21% |
| Total Other Non-Cash Items | 713.23% | 757.16% | -13.72% | 56.29% | -91.90% |
| Change in Net Operating Assets | 338.03% | -16.85% | 691.96% | 19.85% | -42.57% |
| Cash from Operations | 53.69% | -2.00% | 73.42% | 14.52% | -18.73% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -21.14% | 15.68% | 11,800.00% | 61.47% | -5.93% |
| Total Debt Repaid | -500.00% | -3,033.33% | 98.87% | -33.33% | -33.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -24.29% | 12.79% | -89.53% | -29.47% | -2.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 196.38% | 79.71% | -1,348.44% | -73.43% | -1,888.24% |